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Editor’s key points
† Postoperative morbid
events can have long-term
implications for some
patients.
† Which specific
complications affect
patient disability-free
survival and wellbeing
remain largely unknown.
† An ageing surgical
population and growing
demands for cost-effective
healthcare have placed
greater scrutiny on
patient-centred measures
of outcome.
† Clinical epidemiologyof the
entire perioperative
pathway, including late
outcomes, is an important
component of this process.
Background. Previous studies have suggested that there may be long-term harm associated
with postoperative complications. Uncertainty exists however, because of the need for risk
adjustment and inconsistent definitions of postoperative morbidity.
Methods. We did a longitudinal observational cohort study of patients undergoing major
surgery. Case-mix adjustment was applied and morbidity was recorded using a validated
outcome measure. Cox proportional hazards modelling using time-dependent covariates
was used to measure the independent relationship between prolonged postoperative
morbidity and longer term survival.
Results. Data were analysed for 1362 patients. The median length of stay was 9 days and the
median follow-up time was 6.5 yr. Independent of perioperative risk, postoperative
neurological morbidity (prevalence 2.9%) was associated with a relative hazard for long-
term mortality of 2.00 [P¼0.001; 95% confidence interval (CI) 1.32–3.04]. Prolonged
postoperative morbidity (prevalence 15.6%) conferred a relative hazard for death in the first
12 months after surgery of 3.51 (P,0.001; 95% CI 2.28–5.42) and for the next 2 yr of 2.44
(P,0.001; 95% CI 1.62–3.65), returning to baseline thereafter.
Conclusions. Prolonged morbidity after surgery is associated with a risk of premature death
for a longer duration than perhaps is commonly thought; however, this risk falls with time.
We suggest that prolonged postoperative morbidity measured in this way may be a valid
indicator of the quality of surgical healthcare. Our findings reinforce the importance of
research and quality improvement initiatives aimed at reducing the duration and severity of
postoperative complications.
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Surgical morbidity and mortality is a significant public health
issue. Worldwide, it has been estimated that more than 230
million major surgical procedures take place each year,1 and
we know that there is a substantial international variation in
postoperative morbidity2 and mortality.3 Estimates of post-
operative morbidity vary between 7%4 and 50%,5 depending
on the type of surgery, patient risk factors, and on how
complications are defined.6 7
Moreover, the health implications of the surgical insult may
be sustained. The ‘Whitehall study’, which followed more than
6000 British civil servants for a median of 10 yr, found that
absence from work of .7 days after surgery was one of the
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most significant risk factors for reduced long-term survival,
second only to work-absence because of circulatory disease.8
Long-term consequences of postoperative morbidity were
reported in a study of more than 100 000 patients who under-
went eight different types of major surgery, conducted by the
American College of Surgeons’ National Surgical Quality Im-
provement Programme. The investigators observed an associ-
ation between the occurrence of complications within 30 days
of operation and increased long-term mortality (average
follow-up time 8 yr).9 This study used more robust case-mix ad-
justment than the Whitehall study to account for perioperative
risk factors. However, close inspection of survival curves shows
that the risk of long-term harm may vary with time after
surgery; this possible variation was not explored in the report.
To better understand the relationship between postoperative
morbidity and risk of premature death, we linked two prospect-
ive surgical cohort studies with long-term survival in which vali-
dated outcome measures were used, risk adjustment applied,
and in which time was used as an interaction variable, in order
to test the hypothesis that short-term postoperative morbidity
is independently associated with reduced longer term survival.
Methods
The primary objective of this prospective observational cohort
study was to measure the independent relationships between
perioperative risk, inpatient postoperative morbidity, and long-
term survival. Patients undergoing elective, non-cardiac, non-
neurologicalsurgerythatwasclassifiedas ‘major’wererecruited
between the years 2001 and 2005 at the Middlesex Hospital,
London, UK. The patients comprised two separate cohorts. In
Cohort 1, 438 patientswere recruited into a prospective observa-
tional study conducted by the UCL/UCLH Surgical Outcomes
Research Centre (SOuRCe), which validated the Post Operative
Morbidity Survey (POMS) for the first time.6 Patients within
Cohort 2 were participants in a service evaluation of the depart-
ments of surgery and anaesthesia at the same institution
between March 2004 and April 2005. Both studies underwent
ethics review and received approval from the Joint UCLH/UCL
Committee on the Ethics of Human Research. Inclusion and
exclusion criteria for both studies are listed in Supplementary
Appendix S1.
All patients enrolled into the original studies were followed
up using the UK Medical Research Information Service (MRIS),
which provided the date of exit from the National Health
Service for patients who left the UK, and for deceased patients,
date of death. The Ethics and Confidentiality Committee of the
National Information Governance Board granted approval for
disclosure of follow-up data in June 2009 (Study Number
MR1152).
Dataset
The following data were collected on all patients during the ori-
ginal study periods: age, surgical procedure, surgical specialty,
and measures of perioperative risk: the American Society of
Anesthesiologists’ Physical Status Score (ASA-PS)10 and the
variables of the Portsmouth Physiology and Operative Severity
Score for the enUmeration of Morbidity and mortality
(P-POSSUM).11 P-POSSUM consists of 12 physiological variables
(including cardiac and respiratory history, and a number of
haematological and biochemical parameters) and six opera-
tive variables (including urgency and severity of procedure,
malignancy status, and blood loss). Postoperative morbidity
was measured using the POMS, a validated measure of post-
operative harm,6 12 administered on Days 3, 5, 8, and 15 after
surgery. The length of postoperative stay was also recorded.
Two study nurses, who had received training in how to identify
and interpret the preoperative risk and postoperative outcome
variables within the dataset, collected all data prospectively.
Data linkage between the SOuRCe dataset and the MRIS at
the NHS Information Centre provided date of death for non-
surviving cohort members. The study closed on March 1, 2012.
Statistical analysis
Data presentation and management
Continuous data are presented as mean and standard devi-
ation (SD), or median and inter-quartile range (IQR) when not
normally distributed. Categorical data are expressed as per-
centage and counts. Missing data were not imputed and
models were based on complete cases.
Mortality is summarized at hospital discharge, 30 days, 1
and 5 yrafteroperation date. Morbidity is described as a dichot-
omous outcome using the following definitions: any inpatient
morbidity (POMS defined morbidityat anystage), POMSdomain
defined (separate dichotomous outcomes for each of the nine
domains), POMS day defined (separate dichotomous outcomes
for presence or absence of POMS defined morbidity on each of
Days 3, 5, 8, and 15 after surgery).
Dichotomous variables were assessed using the x2 testing
with Bonferroni’s correction for multiple comparisons. The
discrimination of the P-POSSUM model as a perioperative
risk adjuster was tested by measuring the area under the
receiver-operator-characteristic curve for inpatient mortality.
Survival analysis
Time zero was the date of operation; right censoring occurred
on March 1, 2012. Patients who died within 15 days of
surgery were excluded from survival analyses, as Day 15
POMS status was included as an explanatory variable.
Kaplan–Meier plots were used to measure the relationship
between categorical variables and long-term survival. Vari-
ables associated with survival using the log-rank test with
P,0.05 were included in the initial multi-variable model.
P-POSSUM-predicted mortality was entered as a continuous
variable. Although age is a variable within the P-POSSUM
score, it was also separately included as a continuous variable
in the analysis, as it was hypothesized that the effect size of
advanced age would be somewhat greater in a long-term sur-
vival analysis than in a short-term mortality model. Similarly,
although cancer status (based on surgical data) is also included
with the P-POSSUM, cancer status was included as a separate
binary indicator variable in the long-term survival analysis.
The type of postoperative morbidity was entered as separate
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indicator variables for each of the POMS domains that were sig-
nificantly associated with long-term survival on univariate
analysis. Duration of morbidity was defined by the final day
on which POMS-defined morbidity was recorded [final morbid-
ity day (FMD)] and was included as multiple dichotomous vari-
ables. The POMS has not been validated as a ‘score’ (i.e. there is
insufficient internal consistency between domains to be able
to use the POMS as a scale where the number of positive
domains is representative of the severityof postoperative com-
plications).6 Therefore, we did not measure the relationship
between the number of POMS positive domains and long-term
outcome. We also tested for interactions between gastrointes-
tinal (GI) morbidity and general surgery, and cardiac morbidity
and vascular surgery. We tested for, and excluded, collinear
variables before model construction. After constructing the
initial model, the proportional hazards (PH) assumption was
tested using Schoenfeld’s partial residuals and the result con-
firmed by visual examination of a log-minus-log survival plot.
Model development was based on stepwise significance
testing; initially variables were dropped based on P values
.0.10 then P.0.05. Model fit was assessed with the likeli-
hood ratio (LR) testing. All statistical analyses were conducted
using Stata InterCooled (Release 12.1) software (StataCorp LP,
College Station, TX, USA).
Results
General description
Data were available for 1362 patients, 438 in Cohort 1 and 924
in Cohort 2. The cohorts were similar in age, gender, ASA-PS
score, and the distribution of surgical specialities; however,
the first cohort was higher risk [P-POSSUM-predicted mortality
mean (SD) 2.52 (5.36) vs 1.65 (2.76); P,0.001]. The median
length of hospital stay was 9 days (IQR: 6–14). The general
characteristics of the study population are shown in Table 1.
The relationship between FMD and postoperative length of
stay is shown in Table 2. The incidence of postoperative morbid-
ity in different types of surgery is shown in Table 3.
Long-term follow-up data were analysed for 1342 patients;
the reasons for 20 exclusions were: missing follow-up data
(n¼13) and death within 15 days of surgery (n¼7). The major-
ity of patients (79%) was undergoing non-cancer surgery and
had no evidence of malignancy at the time of surgery. There
were 383 deaths in the final group (28.1%); maximum duration
of follow-up was 3895 days (10.7 yr); median follow-up was
2375 days (6.5 yr; IQR 2696–2899 days). Mortality at hospital
discharge, 30 days, 1, and 5 yr is summarized in Table 4. The
area under the receiver-operator-characteristic curve for
P-POSSUM score for predicting inpatient mortality was 0.85
[standard error (SE) 0.03; 95% confidence interval (CI) 0.78–
0.91].
Univariate analysis
The occurrence of postoperative morbidity, of any aetiology
defined by POMS, was associated with reduced long-term sur-
vival (P,0.001). Log-rank comparisons of survival between
patients who did and did not develop pulmonary, renal,
infectious, GI, neurological, cardiac, and pain morbidity all
showed differences at P,0.001. There was also a difference
in survival between patients who were positive and negative
for haematological morbidity (P¼0.002). There was no dif-
ference in long-term outcome based on the development
of wound morbidity (P¼0.42).
Multi-variable analysis
When a model was initially constructed and the PH assumption
tested, both tests showed that the PH assumption was vio-
lated. Plotting baseline cumulative hazard for patients with dif-
ferent durations of postoperative morbidity demonstrated a
‘step’ in the cumulative hazard at 3 yr after operation in
patients whose FMD was Day 15. No such change in trajectory
was seen for the patients who either did not have any post-
operative morbidity recorded, or whose FMD was 3, 5, or 8
(see Fig. 1). Therefore, time was included as an interaction
with FMD 15, in order to avoid the need to comply with the
PH assumption.13 14 The follow-up duration was split into
three periods: 0–365, 366–1095,.1095 days (3 yr). The unre-
stricted model included the interactions of each of these time
categories with FMD 15.
The full model therefore consisted of 27 variables; stepwise
analyses led to a final model of 11 variables based on sig-
nificance testing; this model is listed in Table 5. The LR x2
test for the final model was 292.7, giving a P-value of
,0.0001, thus demonstrating that the unrestricted model was
not different from the final model.
Table 1 Baseline patient characteristics
Variable
Number 1362
Mean age (SD) 63.5 (15.3)
Female gender (%) 773 (56.8)
Ethnicity: n (%)
Black or Black British 69 (5.1)
White or White British 1198 (88.0)
Asian or Asian British 44 (3.2)
Other 49 (3.6)
Missing 2 (0.2)
P-POSSUM predicted mortality
Mean (SD) 1.9 (3.8)
Median (IQR) 1.0 (0.6–1.8)
Surgical Specialty: n (%)
Orthopaedic 855 (62.8)
General 296 (21.7)
Urology 147 (10.8)
Vascular 64 (4.7)
ASA-PS class: n (%)
I 223 (16.4)
II 808 (59.3)
III 299 (22.0)
IV 13 (1.0)
Missing 19 (1.4)
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The perioperative risk factors of age, cancer history,
P-POSSUM predicted risk, and the procedure categories of
general or vascular surgery were all independently associated
with reduced long-term survival. In addition, the occurrence of
neurological morbidity (prevalence 2.94%) after surgery was
associated with a relative hazard for long-term mortality of
2.00 (P¼0.001; 95% CI 1.32–3.04). Morbidity which persisted
until at least Day 15, and thus associated with a greater than
average length of stay within this cohort, was associated
with a relative hazard of 3.51 (95% CI 2.28–5.42) for the first
year after surgery, 2.44 for the next 2 yr (95% CI 1.62–3.65),
and returning to baseline thereafter.
Discussion
This study shows that in major elective, non-cardiac, non-
neurological surgery, prolonged postoperative morbidity (as
defined by the POMS) is independently associated with an
increased risk of death for up to 3 yr after surgery. This reiter-
ates the association shown by Khuri and colleagues9 and
others15 but using different approaches to measurement of
both risk and morbidity (complications); this therefore
increases the likelihood that this relationship may be
causal.16 We believe that this is the first study to demonstrate
that this increased risk varies with time, returning to baseline
after 3 yr. The findings of this study should invigorate current
efforts to make surgery safer. Furthermore, we suggest that
prolonged postoperative morbidity is a valid measure of the
quality of surgical healthcare, which, when adjusted for
perioperative risk, would be a useful outcome measure for clin-
ical effectiveness studies and for comparative audit.
Methodological limitations
Before putting these results into context, it is worth addressing
some methodological issues. Our study was conducted in a
single centre and recruited solely elective patients, and as a
result there are limits to the generalizability of our findings.
No adjustment was made for the effect that social deprivation
might have had on long-term outcome: life expectancy is
strongly related to index of deprivation17 and therefore this
may have influenced postoperative survival. The risk adjust-
ment was confined by the limitations of the original SOuRCe
dataset, and there are risk factors for both perioperative and
long-term outcome that were not included in the model (e.g.
diabetes mellitus). It is therefore possible that the case-mix
adjustment was not as complete as possible and that the
presence of latent confounding may have led to an overesti-
mation of the association between postoperative morbidity
and long-term outcome. However, the P-POSSUM model has
been widely validated as a perioperative risk adjuster,18 and
in this population, we found it to be highly accurate for the pre-
diction of short-term mortality, therefore justifying its use.
Finally, there are also limitations of the POMS as an outcome
measure. It is highly sensitive: it was developed to detect mor-
bidity of a type that would prolong hospital stay; therefore,
POMS definitions encompass some relatively minor and
process-related morbidity, such as the presence of a urinary
catheter. This may explain the seemingly high morbidity
Table 2 Relationship between FMD and postoperative length of stay (days)
Postoperative length
of stay (days)
Total cohort
(n51362)
No morbidity
(n5368)
FMD 3
(n5266)
FMD 5
(n5278)
FMD 8
(n5238)
FMD 15
(n5212)
Median (IQR) 9 (6–14) 6 (4–7) 7 (6–9) 8 (7–11) 13 (11–15) 25 (19.5–36)
Table 3 Incidence of postoperative morbidity according to surgical specialty (%)
Total (n51362) Orthopaedic (n5855) General (n5296) Urology (n5147) Vascular (n564)
Any morbidity 73.0 62.9 91.0 91.1 82.8
Any pulmonary 33.1 22.6 52.4 50.3 45.3
Any infection 40.3 32.4 47.3 64.6 57.8
Any renal 43.6 31.1 59.5 76.2 62.5
Any GI 41.0 23.9 83.8 55.1 39.1
Any cardiac 6.8 5.6 7.4 4.8 23.4
Any neurological 2.9 2.5 2.0 4.8 9.4
Any wound 11.0 11.1 11.5 9.5 10.9
Any haematology 8.1 7.8 6.8 10.9 10.9
Any pain 33.4 20.1 60.8 53.7 37.5
POMS+ Day 3 67.8 55.6 90.2 90.5 75.0
POMS+ Day 5 49.9 35.8 77.4 70.1 64.1
POMS+ Day 8 31.5 20.9 53.0 44.9 42.2
POMS+ Day 15 15.6 8.2 29.4 26.5 25.0
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figures, particularly on postoperative day 3, when it is perhaps
more fair to say that POMS reflects the ‘absence of full recovery’
defined by the ongoing delivery of care, rather than ‘true’ mor-
bidity.6 However, the morbidity rates for the latter days are
broadly similar to previous reports using the POMS tool in
similar patient cohorts.12
Clinical implications
Our data support the notion that the occurrence of post-
operative morbidity is a major public health issue, which (in
terms of adjusted risk) is comparable in scale with the long-
term consequences of obesity19 and diabetes mellitus.20
However, unlike the harm associated with these diseases, the
long-term risk, we have described may be more amenable to
prevention, both through progress in our understanding of
the pathophysiology of adverse surgical outcomes and via im-
provement in the quality of surgical healthcare. For example,
we have demonstrated an association between postoperative
neurological morbidity and the risk of reduced long-term sur-
vival; previous studies have also found this link.21 Postoperative
cognitive dysfunction and delirium is a fairly common event,
particularly in the elderly.22 21 Studies in animal models have
pointed to a plausible immunological mechanism for the de-
velopment of postoperative cognitive decline, which is trig-
gered by the physiological response to injury; this immune
response could serve as a target for therapy.23 24
Additionally, it is an important observation that the majority
of patients in this cohort were undergoing joint replacement
surgery, which is aimed at improving quality of life, as opposed
to, for example, cancer surgery, aimed at prolongation of life.
The implications of prolonged postoperative morbidity and the
increased risk of premature death are particularly important in
this sub-group of patients: understanding and quantifying this
potential risk should inform the consent process and potentially
influence the views of both the patient and clinical team when
making decisions on whether to undertake surgery in higher
risk patients.
Prolonged postoperative morbidity as a quality metric
Short-term postoperative morbidity and mortality continues to
vary across providers and healthcare systems.3 25 26 While it is
true that some complications may be unavoidable, particularly
Table 4 Comparison of postoperative mortality (%) according to surgical specialty. *With Bonferroni’s correction for four analyses
Inpatient (n51362) 30 day (n51362) 1 yr (n51347) 5 yr (n51339)
All patients 1.5 1.1 6.8 20.7
Orthopaedics 0.5 0.6 3.0 13.4
Urology 1.4 0 6.2 18.3
General 3.4 2.4 16.4 40.4
Vascular 7.8 4.7 15.9 32.8
P-value* ,0.001 ,0.01 ,0.001 ,0.001
1.00
Cumulative hazard estimates by final morbidity day
Analysis time (days)
0
0.00
0.20
0.40
0.60
0.80
1000 2000 3000 4000
Final morbidity day 15
Final morbidity day 5
No POMS defined morbidity
Final morbidity day 8
Final morbidity day 3
Fig 1 Cumulative hazard plot for mortality after postoperative morbidity according to FMD.
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in patients with multiple co-morbidities, it is also true that pro-
longed morbidity, major complications, and ultimately death
may be mitigated against by improved structures and pro-
cesses in healthcare: this ‘failure-to-rescue’ concept has
widely been studied in the USA.26 27 Wider implementation of
strategies such as goal-directed fluid therapy,28 29 enhanced
recovery (or ‘fast-track surgery’) programmes,30 and the ex-
pansion of critical care facilities so that a greater number of
high-risk patients can be managed in high-acuity ward
areas3 may contribute to a reduction in the disease burden
that arises from the development of postoperative complica-
tions.
Currently, mortality and the length of stay are two of
the most commonly measured postoperative outcomes;
however, both have limitations. Although there are some high-
risk procedures which provide exceptions,31 overall surgical
mortality is low in high-resource nations. Thus, in order to be
able to make meaningful comparisons between institutions
and teams, an outcome measure with a higher prevalence
(such as complication rates) is required.32 33 Furthermore,
while the length of stay is an attractive quality metric, as it is
easy to measure, it is also prone to biases that are not related
to true patient outcome or the quality of care, such as socio-
economic status.34
Longer term impact of prolonged postoperative
morbidity: potential hypotheses
Our study challenges previous temporal associations—and
therefore potential mechanistic explanations—for the rela-
tionship between non-specific postoperative morbidity and
longer term risk of death. We believe that by using time-
dependent covariates, our work is the first to demonstrate
that while the impact of prolonged postoperative morbidity
on survival is of greater duration than may be intuitive, that
this risk falls progressively until reaching baseline after 3 yr.
This long tail suggests that the underlying mechanism confer-
ring the risk must persist for a considerable period of time, and
possibly for long after the resolution of clinically apparent mor-
bidity. Currently, the most plausible explanation—and one that
has garnered considerable support—is that the agent confer-
ring the risk is inflammation.35 If inflammation does prove to
be the underlying process leading to long-term risk, then
this too should be amenable to mitigation by either changing
practices or testing anti-inflammatory therapies.36
As with all epidemiological data, our results should be
regarded as hypothesis generating rather than confirmatory.
From these data, we are unable to prove that some or all of
the prolonged postoperative morbidity might have been
related to the quality of inpatient care and therefore might
have been avoidable. Unmeasured confounding from patient
comorbidities may account for some of the total effect,
which leads to prolonged morbidity; however, it is unlikely
that patient-related risk alone is the sole determinant of
outcome: our study recapitulates the findings of others from
large observational cohorts and ‘real-world’ audit data and
using a variety of risk and outcome measures. Furthermore,
we cannot assume that by preventing prolonged postopera-
tive morbidity that long-term survival would improve; similar
confounders may influence the longer term disease trajectory.
However, our studyprovides important data that may be used to
support future work evaluating the underlying mechanisms of
postoperative morbidityand strategies which might be targeted
at mitigating risk, either before surgery, or after discharge from
hospital.
In conclusion, we have demonstrated that postoperative
neurological morbidity is associated with reduced survival in
the longer term, and that prolonged postoperative morbidity
of any aetiology is associated with increased mortality risk
for up to 3 yr after the surgical insult. We suggest that pro-
longed postoperative morbidity is a valid and important
quality metric for the evaluation of perioperative care. Our
findings support the need for future work directed at imple-
menting structure and process-related changes in healthcare
delivery in order to reduce postoperative morbidity.
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